A man in his eighties with a past medical history notable for 4 primary cutaneous melanomas (all AJCC Stage IA or 0), squamous cell skin cancer, and severe actinic damage presented for routine skin cancer surveillance follow-up.
Colonization of basal cell carcinoma (BCC) by melanoma cells is a unique and uncommonly reported cutaneous entity. We describe a bluish nodule on the left forearm found during routine skin cancer surveillance examination with suspicious dermatoscopic findings including central-blue-white veil, sparse atypical dots, and a surrounding pink vascular blush with focal irregular tan-brown pigmentation at the periphery. Histopathology demonstrated a pigmented BCC with an overlying and adjacent melanoma in situ (MIS), as well as colonization of the BCC nodule by melanoma cells. We performed a review of the literature on the topic and discuss other presentations of cutaneous neoplasms composed of both BCC and melanoma, including collision, combined, and biphenotypic tumors. The prognostic and management challenges inherent to this distinctive neoplasm are summarized. 
Discussion
Cutaneous neoplasms with two or more distinct cell populations are rare but well documented entities that frequently pose a diagnostic challenge to both clinicians and pathologists. Multiple unique presentations regarding the specific co-existence of BCC with melanoma or melanocytic nevi [4] [5] [6] [7] [8] [9] [10] , but also with melanocytic nevi [8, [11] [12] [13] [14] [15] and blue nevi [16, 17] . Boyd and Rapini performed a retrospective evaluation of 40,000 cutaneous biopsies and found 69 examples of collision tumors. BCC with melanocytic nevus (n=14) was the most frequently identified collision tumor in their series [11] . The coexistence of BCC and melanoma was not found. [37] . The authors further compared the density of melanocytes in BCC tumor islands to a single example of BCC colonized by MIS and found that when BCC is infiltrated by melanoma cells, the melanocyte density is higher and clusters of melanocytes can be observed [37] .
Including the case presented herein, the majority of patients who have developed colonization of BCC by MIS have been males (5/6), often with significant risk factors for melanoma including a history of prior invasive melanomas [32] [33] [34] , severe actinic damage [32, 33] , CDKN2A gene mutation [32] , or xeroderma pigmentosum variant [33] . Anatomic sites with chronic ultraviolet light exposure including the face, ears, forearm, and scalp are most frequently affected. Dermatoscopy or reflectance confocal microscopy (RCM) was rarely used in the evaluation of these neoplasms. Recently, these two diagnostic technologies have emerged as valuable tools for the diagnosis of cutaneous neoplasms with two or more distinct cell populations [8, 15, 32, 40, 41] . In one study of 20 benignmalignant collision tumors, dermatoscopy and RCM was successful in identifying the malignant tumor in 14 and 19 melanocytes, similar to that seen when MIS extends along adnexa, and therefore does not represent true invasion [35] .
We agree with previous authors who have similarly stated that these lesions are unlikely true invasive melanomas with metastatic potential [32] [33] [34] [35] [36] . Nonetheless, the following two cases highlight the caution that should be exercised before issuing a diagnosis of BCC colonization by MIS. In summary, we report a case that may best be interpreted as a melanoma in situ colonizing a BCC. We are of the opinion that these tumors developed independent of each other and the BCC served as a conduit for the extension of melanoma cells. The alternate hypothesis of a biphenotypic tumor with a common precursor diverging towards both epithelial and melanocytic differentiation seems less plausible. Given the absence of adequate prospective data on outcomes, we suggest that these neoplasms should be treated on an individual case-by-case basis, taking into account the adequacy of the original biopsy, the anatomic site of the lesion, and the age and underlying comorbidities of the patient. New technologies, particularly RCM, may be useful in accurately identifying these tumors prior to skin biopsy.
